Palatin Technologies (PTN) Inventory (2020 - 2023)
Palatin Technologies' (PTN) quarterly Inventory came in at $1.6 million in Q3 2023, up 86.28% on a YoY basis from $857975.0 in Q3 2022, and up 203.85% quarter-over-quarter from $526000.0 in Q2 2023.
Analysis
Palatin Technologies (PTN) Inventory (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has reported Inventory for 4 consecutive years, with $1.6 million the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Inventory rose 86.28% year-over-year to $1.6 million; the trailing twelve-month figure through Sep 2023 stood at $1.6 million (up 86.28% YoY), and the FY2023 full-year result was $526000.0, down 44.31% from the prior year.
- Inventory rose to $1.6 million in Q3 2023 per PTN's latest filing, from $526000.0 in the prior quarter.
- Across five years, Inventory topped out at $6.1 million in Q1 2021 and bottomed at $526000.0 in Q2 2023.
- Historically, Inventory has averaged $2.1 million across 4 years, with a median of $1.1 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Inventory tumbled 83.12% in 2022, then soared 86.28% in 2023.
- Over 4 years, Inventory stood at $6.0 million in 2020, then slumped by 82.11% to $1.1 million in 2021, then decreased by 29.63% to $759268.0 in 2022, then soared by 110.5% to $1.6 million in 2023.
- According to Business Quant data, Inventory over the past three periods registered $1.6 million, $526000.0, and $630033.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 526,000.00 |
| Mar 31, 2023 | 630,033.00 |
| Dec 31, 2022 | 759,268.00 |
| Sep 30, 2022 | 857,975.00 |
| Jun 30, 2022 | 944,471.00 |
| Mar 31, 2022 | 1.03 Mn |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.16 Mn |
| Mar 31, 2021 | 6.11 Mn |
| Dec 31, 2020 | 6.03 Mn |
| Sep 30, 2020 | 5.79 Mn |